OBJECTIVE
Cenobamate is approved for treatment of focal seizures in adults, but evidence on non-seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal-onsEt SeizureS (BLESS) study evaluated patient- and clinician-reported outcomes for up to 52 weeks of cenobamate trea...
Simona Lattanzi, G. d'Orsi, M. T. Di Claudio et al.· Epilepsia· 0 citations
A novel interpretable framework is proposed for decoding EEG signals from subjects with Alzheimer's disease, Creutzfeldt–Jakob disease, and healthy controls, while providing insight into the model's learned characteristics, demonstrating both the effectiveness and interpretability of EEGDecoder-x.
Muhammad Suffian, Nadia Mammone, C. Ieracitano et al.· Frontiers in Neurology· 0 citations
Seizure freedom can improve all domains of QoL, but mainly Seizure worry, although this can be negatively affected by depressed mood, and improvement in the domain of Social functioning requires a period of sustained seizure freedom longer than 6 months to improve, and it is negatively influenced by persistent depresse...
Marco Mula, S. Borghs, Bruno Ferrò et al.· Epilepsia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.